Silver MPN Center

09/11/2024

Join Dr. Ellen Ritchie at the The Leukemia & Lymphoma Society National Virtual Conference where she’ll be speaking to patients, caregivers, and loved ones about ( ). Register and learn more here:

,The Leukemia & Lymphoma Society is proud to present this free VIRTUAL education event to blood cancer patients, survivors, family members, caregivers, and healthcare professionals.* Experts in the areas of blood cancer research, treatment, and survivorship will present information on each topic....

03/01/2024

The free The Leukemia & Lymphoma Society Tri-State Blood Cancer Conference for patients, loved ones and healthcare professionals is taking place on March 9 in NYC. Register to join Dr. Joseph Scandura and hear him speak about ( ): https://bit.ly/3T4vA0i

12/28/2023

Dr. Joseph Scandura spoke with Targeted Oncology about the potential role of pelabresib for patients with and current evaluating this therapy option:

In an interview with Targeted Oncology, Joseph M. Scandura, MD, PhD, discussed research on pelabresib for the treatment of patients with myeloproliferative neoplasms.

12/26/2023

Congratulations to Dr. Andrew Schafer for being selected as one of the 2023 CURE Today MPN Heroes for his dedication to research and care for patients with :

CURE® honored eight MPN Heroes, which ranged from medical professionals to patients and caregivers, on the contributions they made in the field.

08/11/2023

Dr. Ghaith Abu-Zeinah joined PV Reporter to break down what “disease modification” means for patients:

MPN Specialist Dr. Abu-Zeinah unveils 'disease modification' and exciting late-stage clinical trials in this insightful interview.

03/23/2023

How is Chronic Eosinophilic classified? Hear from Dr. Andrew Schaefer on how this type of manifests itself in the body:

Chronic eosinophil diseases are types of blood disorders associated with abnormally high numbers of a rare white blood cell type called eosinophils. All heal...

03/21/2023

Do you have questions about , including causes, symptoms, treatment, and more? The Weill Cornell Medicine Silver Center has answers: https://bit.ly/3OONsJM

03/17/2023

is a type of chronic caused by abnormal blood stem cells that overproduce platelets:

Essential Thrombocythemia (ET) is a type of chronic myeloproliferative neoplasm caused by abnormal blood forming cells that overproduce a blood cell called platelets (aka thrombocytes). Like CML, ET is also thought to be caused by mutations in blood forming stem cells (aka hematopoietic stem cell, H...

03/13/2023

breakthroughs have led to a number of treatment possibilities for that weren’t previously available: https://bit.ly/3Rt9ovvOther

03/09/2023

People with can experience abnormal bleeding due to low platelet counts. Here’s what to know: https://bit.ly/3Y4hn4v

03/07/2023

are characterized by abnormal cell growth, one of the classifications of . Learn more why are defined this way:

Cancer is caused by cells with abnormalities that grow and take over a part of tissue. Myeloproliferative neoplasms are considered cancer because they are ch...

03/02/2023

Ruxolitinib is an oral medication used to treat and and works by blocking the excess JAK protein signaling that overproduces blood cells: https://bit.ly/3JFA2PW